Peptide-Delivered Antisense Molecules Block Enterococcus Growth and 95% of Biofilm Formation
Cell-penetrating peptide-conjugated antisense PNAs targeting ftsZ and efaA genes eliminated Enterococcus faecalis growth and reduced biofilm formation by 95% without mammalian cell toxicity.
Quick Facts
What This Study Found
Anti-ftsZ PNAs completely inhibited E. faecalis growth, while CPP-conjugated anti-efaA PNAs reduced efaA gene expression and biofilm formation by 95%, with no mammalian cell toxicity.
Key Numbers
Anti-ftsZ: eliminated growth; anti-efaA: 95% reduction in expression and biofilm; no MCF7 toxicity
How They Did This
In-vitro study using antisense PNAs targeting ftsZ and efaA genes in E. faecalis ATCC 29212, with electroporation and CPP delivery, measuring growth inhibition, biofilm formation, gene expression, and cytotoxicity.
Why This Research Matters
Antibiotic-resistant Enterococcus is a growing hospital threat. Gene-targeted PNA approaches could provide precision antimicrobials that bypass conventional resistance mechanisms.
The Bigger Picture
This represents a paradigm shift from conventional antibiotics to gene-targeted antimicrobials, using CPP delivery to silence essential bacterial genes — potentially overcoming the antibiotic resistance crisis.
What This Study Doesn't Tell Us
In-vitro study with a single bacterial strain; electroporation is not clinically viable for ftsZ delivery; CPP-PNA delivery needs in-vivo testing; manufacturing scalability not addressed.
Questions This Raises
- ?Can CPP-PNA conjugates be effective against antibiotic-resistant Enterococcus strains in vivo?
- ?How do CPP-PNA antimicrobials compare in cost and scalability to conventional antibiotics?
- ?Could this approach be broadened to target other nosocomial pathogens?
Trust & Context
- Key Stat:
- 95% biofilm reduction CPP-conjugated anti-efaA PNAs nearly eliminated biofilm formation in Enterococcus faecalis
- Evidence Grade:
- Strong in-vitro proof of concept with gene expression validation and cytotoxicity testing, but limited to one bacterial strain and in-vitro conditions.
- Study Age:
- Published in 2020; antisense PNA antimicrobials remain an active area of research for combating antibiotic-resistant infections.
- Original Title:
- Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis.
- Published In:
- Microbial pathogenesis, 139, 103907 (2020)
- Authors:
- Narenji, Hanar, Teymournejad, Omid, Rezaee, Mohammad Ahangarzadeh, Taghizadeh, Sepehr, Mehramuz, Bahareh, Aghazadeh, Mohammad, Asgharzadeh, Mohammad, Madhi, Masoumeh, Gholizadeh, Pourya, Ganbarov, Khudaverdi, Yousefi, Mehdi, Pakravan, Asrin, Dal, Tuba, Ahmadi, Raman, Samadi Kafil, Hossein
- Database ID:
- RPEP-05026
Evidence Hierarchy
Frequently Asked Questions
What are peptide nucleic acids (PNAs)?
Synthetic molecules that bind to bacterial RNA and block gene expression. When conjugated to cell-penetrating peptides, they can enter bacteria and silence essential genes.
How do CPP-PNAs fight antibiotic-resistant bacteria?
They target and silence specific genes essential for bacterial survival and biofilm formation, bypassing the conventional resistance mechanisms that make standard antibiotics ineffective.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05026APA
Narenji, Hanar; Teymournejad, Omid; Rezaee, Mohammad Ahangarzadeh; Taghizadeh, Sepehr; Mehramuz, Bahareh; Aghazadeh, Mohammad; Asgharzadeh, Mohammad; Madhi, Masoumeh; Gholizadeh, Pourya; Ganbarov, Khudaverdi; Yousefi, Mehdi; Pakravan, Asrin; Dal, Tuba; Ahmadi, Raman; Samadi Kafil, Hossein. (2020). Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis.. Microbial pathogenesis, 139, 103907. https://doi.org/10.1016/j.micpath.2019.103907
MLA
Narenji, Hanar, et al. "Antisense peptide nucleic acids againstftsZ andefaA genes inhibit growth and biofilm formation of Enterococcusfaecalis.." Microbial pathogenesis, 2020. https://doi.org/10.1016/j.micpath.2019.103907
RethinkPeptides
RethinkPeptides Research Database. "Antisense peptide nucleic acids againstftsZ andefaA genes in..." RPEP-05026. Retrieved from https://rethinkpeptides.com/research/narenji-2020-antisense-peptide-nucleic-acids
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.